-
- Pawel K Wlodarski and Jaroslaw Jozwiak.
- Medical University of Warsaw, Center for Biostructure Research, Department of Histology and Embryology, Poland. pawel.wlodarski@am.edu.pl
- Expert Opin. Ther. Targets. 2008 Apr 1; 12 (4): 449-61.
BackgroundPresent treatment of medulloblastoma, the most common malignant brain tumor in children, includes surgery, radiotherapy and chemotherapy. In spite of radical treatment, only about 70% of patients survive. Also side effects of the treatment are severe, mostly due to applied radiotherapy.ObjectiveThe following review highlights potential molecular targets for pharmacotherapy of medulloblastoma, as well as the directions in which, in the authors' opinion, the field will evolve in near future.MethodsPresent literature on pathways engaged in formation of medulloblastoma is summarized in the context of their available pharmacological modulators.ResultsThe quest for a better treatment modalities includes better risk stratification methods, including molecular profiling of individual tumors and a search for new small molecules capable of inhibiting hyperactive signaling pathways. Several candidates for such agents are being tested presently.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..